Clinuvel Plots Competition To Incyte In Vitiligo Space
Trial Aimed At Expanding Label On Scenesse
The Australian company is steadily growing its photoprotective drug in adults with erythropoietic protoporphyria but also sees a big opportunity in the pigment loss disorder.
